Login    Join free Add to favorites    中文
home > news > 4th Annual Congress on Drug Discovery & Designing, July 2017, Thailand
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
4th Annual Congress on Drug Discovery & Designing, July 2017, Thailand

hits:1149     Date:12/02/16

4th Annual Congress on Drug Discovery & Designing

Venue: Bangkok, Thailand.
Dates: July 03-05, 2017
Theme: Accelerate Drug Discovery and identify new methods of Drug Design
Conference Series LLC invites all the participants across the globe to attend "4th Annual Congress on Drug Discovery & Designing scheduled on July 03-05, 2017 at Bangkok, Thailand. Which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Drug Discovery Congress focuses on discussing the treatment strategies, risk management and consequences and challenges in drug design and discovery industry. Drug Discovery Congress provides a platform to critically analyse and understand the methods and mechanisms.
Why to attend???
Join your peers around the world focused on learning about Drug Discovery Congress and related advances, This unique international conference will opportunity to reach the largest assemblage of participants from the Pharma community to gather and share their insights and convey recent developments in the field of drug discovery research and current challenges and possibilities in modelling a new drug and breakthroughs in drug development, Current Trends and Emerging targets in drug discovery & Patented drug design. This is a true forum where ideas and discussion is driven by the participants and interaction with peers and others leads to fruitful outcomes
Drug Discovery Congress is a 3-day event offering the Exhibition, at venue to showcase the new and emerging technologies and have wider sessions involving  Keynote presentationOralYRF ( student presentation), postere-poster presentations. World-renowned speakers and eminent delegates across the globe attending the conference, to share their valuable presentation on the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.
Target Audience: 
  • CEOs, CROs, Directors, Managers and research associates in pharmaceutical industry in the drug or device industries (both innovator and generic)
  • Academic and Industrial Scientists Associated with Discovery, Formulation and The Delivery of Drugs
  • Regulatory and Clinical Scientists Involved In Drug Development
  • Researchers, Education providers In Clinical Pharmacy, Pharmacology and Toxicology
  • Students and Postdoctoral Fellows In All Areas of The Pharmaceutical Sciences
  • Government Agencies Involved In Chemical Safety Assessment
  • Medical Practitioners Such As Clinical Pharmacologists, Clinical Toxicologists.
Conference Series LLC is very delighted to invite you all to the "4th Annual Congress on Drug Discovery & Designing" (Drug Discovery Congress) scheduled on July 03-05, 2017 at Bangkok Thailand. Conference Series LLC organizes a conference series of 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Track 15: Drug Designing
Market Analysis
Drug Discovery Informatics Market size was $ 1.6 billion in 2015 and is anticipated to reach around $ 6.5 billion by 2023. High usage of information technology in data analysis and data mining in terms of drug development, progressions in software versions for data aggregation, processing and analysis, data visualization; and increased use for cloud based services are key factors to drive the drug discovery informatics market.
Global drug discovery informatics market size is expected to record considerable progress over the forecast timeframe because of the introduction of novel platforms and related data analysis services obtained from clinical trials. Sequence analysis platforms related services generated the largest revenue share and are estimated to dominate the industry over the forecast period due to their increasing acceptance and introduction of the advanced genetic sequencing of the genome which provides new opportunities in lead identification.  
Global Business Intelligence (GBI) Research finds that the total drug discovery and development market size in the top seven Asian countries was estimated at $11.2 billion in 2015 and is forecast to reach $17.3 billion by the end of 2018.
The drug discovery and development market in seven major countries in Asia, namely China, India, Russia, Japan, Singapore, Taiwan and South Korea.
Why Bangkok, Thailand?
Bangkok is the capital and most populous city of Thailand. The city has a population of over 8 million, or 12.6 percent of the country's population.
Thailand's pharmaceutical industry is one of the largest and most developed in Southeast Asia, with projections that it will have the eighth largest pharmaceutical market in the Asia Pacific region in 2016. The country's unique universal medical scheme and its position as a hub of regional distribution have formed a highly attractive market. As the Thai population grows, urbanizes, becomes more affluent, ages and is increasingly sedentary, demand for better healthcare will increase. Equally significant, the Thai generic sector is growing, especially in the public sector, where the government has encouraged its use over patented drugs in order to cut costs. For instance, Greater Pharma has recently launched its first generic inhaler drug for the treatment of osteoporosis, making it the first company in Southeast Asia to manufacture successfully a generic version of this drug.
Drop us an email for Program enquiry.
Sponsors / Exhibiting / Advertising.
General Queries.
Related News>> more

Copyright(C) 2006-2018 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙